SanBio Company Limited (4592.T)
JPY 2299.0
(-0.99%)
JPY 2299.0
(-0.99%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | - JPY | 0.0% |
| 2022 | - JPY | 0.0% |
| 2021 | - JPY | 0.0% |
| 2020 | - JPY | -100.0% |
| 2019 | 447.22 Million JPY | -39.7% |
| 2018 | 741.61 Million JPY | 51.19% |
| 2017 | 490.5 Million JPY | -48.34% |
| 2016 | 949.54 Million JPY | -19.16% |
| 2015 | 1.17 Billion JPY | -63.62% |
| 2014 | 3.22 Billion JPY | 1480.73% |
| 2013 | 204.28 Million JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | - JPY | 0.0% |
| 2024 Q1 | - JPY | 0.0% |
| 2023 Q4 | - JPY | 0.0% |
| 2023 Q3 | - JPY | 0.0% |
| 2023 Q1 | - JPY | 0.0% |
| 2023 FY | - JPY | 0.0% |
| 2023 Q2 | - JPY | 0.0% |
| 2022 Q4 | - JPY | 0.0% |
| 2022 Q2 | - JPY | 0.0% |
| 2022 FY | - JPY | 0.0% |
| 2022 Q1 | - JPY | 0.0% |
| 2022 Q3 | - JPY | 0.0% |
| 2021 Q4 | - JPY | 0.0% |
| 2021 FY | - JPY | 0.0% |
| 2021 Q1 | - JPY | 0.0% |
| 2021 Q2 | - JPY | 0.0% |
| 2021 Q3 | - JPY | 0.0% |
| 2020 Q2 | - JPY | 0.0% |
| 2020 Q4 | - JPY | 0.0% |
| 2020 Q3 | - JPY | 0.0% |
| 2020 FY | - JPY | -100.0% |
| 2020 Q1 | - JPY | -100.0% |
| 2019 FY | 447.22 Million JPY | -39.7% |
| 2019 Q4 | 22.88 Million JPY | 768.28% |
| 2019 Q3 | -3.42 Million JPY | -101.44% |
| 2019 Q2 | 238.37 Million JPY | 25.86% |
| 2019 Q1 | 189.39 Million JPY | 9.65% |
| 2018 Q4 | 172.72 Million JPY | 12.67% |
| 2018 Q3 | 153.29 Million JPY | -40.38% |
| 2018 Q2 | 257.14 Million JPY | 62.29% |
| 2018 Q1 | 158.45 Million JPY | 32.91% |
| 2018 FY | 741.61 Million JPY | 51.19% |
| 2017 Q3 | 121.37 Million JPY | -3.72% |
| 2017 Q1 | 123.87 Million JPY | -35.33% |
| 2017 FY | 490.5 Million JPY | -48.34% |
| 2017 Q4 | 119.21 Million JPY | -1.78% |
| 2017 Q2 | 126.05 Million JPY | 1.76% |
| 2016 Q3 | 73.67 Million JPY | 25.42% |
| 2016 Q4 | 191.53 Million JPY | 159.99% |
| 2016 FY | 949.54 Million JPY | -19.16% |
| 2016 Q2 | 58.73 Million JPY | -90.61% |
| 2016 Q1 | 625.59 Million JPY | 732.35% |
| 2015 Q3 | 688.23 Million JPY | 443.82% |
| 2015 FY | 1.17 Billion JPY | -63.62% |
| 2015 Q1 | 284.69 Million JPY | 160.91% |
| 2015 Q2 | 126.55 Million JPY | -55.55% |
| 2015 Q4 | 75.16 Million JPY | -89.08% |
| 2014 FY | 3.22 Billion JPY | 1480.73% |
| 2014 Q4 | 109.11 Million JPY | 0.0% |
| 2013 FY | 204.28 Million JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | 100.0% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | 100.0% |
| GNI Group Ltd. | 26.01 Billion JPY | 100.0% |
| Linical Co., Ltd. | 12.3 Billion JPY | 100.0% |
| Trans Genic Inc. | 13.08 Billion JPY | 100.0% |
| MEDINET Co., Ltd. | 661.54 Million JPY | 100.0% |
| Soiken Holdings Inc. | 5.15 Billion JPY | 100.0% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | 100.0% |
| AnGes, Inc. | 152.98 Million JPY | 100.0% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | 100.0% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 100.0% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | 100.0% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | 100.0% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | 100.0% |
| CanBas Co., Ltd. | - JPY | NaN% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | 100.0% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | 100.0% |
| Chiome Bioscience Inc. | 682.46 Million JPY | 100.0% |
| Kidswell Bio Corporation | 2.43 Billion JPY | 100.0% |
| PeptiDream Inc. | 28.71 Billion JPY | 100.0% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | 100.0% |
| Ribomic Inc. | - JPY | NaN% |
| Healios K.K. | 121 Million JPY | 100.0% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | 100.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | 100.0% |
| Delta-Fly Pharma, Inc. | - JPY | NaN% |
| StemRIM | - JPY | NaN% |
| CellSource Co., Ltd. | 4.51 Billion JPY | 100.0% |
| FunPep Company Limited | 530 Thousand JPY | 100.0% |
| Kringle Pharma, Inc. | 69.25 Million JPY | 100.0% |
| Stella Pharma Corporation | 269.49 Million JPY | 100.0% |
| TMS Co., Ltd. | - JPY | NaN% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | 100.0% |
| Cuorips Inc. | 23.1 Million JPY | 100.0% |
| K Pharma,Inc. | 1 Billion JPY | 100.0% |
| Takara Bio Inc. | 43.5 Billion JPY | 100.0% |
| ReproCELL Incorporated | 2.42 Billion JPY | 100.0% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | 100.0% |
| StemCell Institute Inc. | 2.48 Billion JPY | 100.0% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | 100.0% |
| CellSeed Inc. | 190.13 Million JPY | 100.0% |